Garden Bonds | New Bond Analysis

Previous "New Bond Analysis" can be searched by clicking on the topic tag above.

Next, it's new bond analysis:

Bond Name: Garden Bonds

Subscription Time: March 6th

Payout Date: March 8th

Company Overview:

Garden Biotech's main business is the research, production, and sales of vitamin D3 series products.

The company has achieved a compound annual growth rate (CAGR) of 19.15% in revenue and 16.05% in net profit over the past three years, with excellent revenue and profit growth.

Analysis: The stock is currently undervalued, with a year-on-year decrease of 4.89% in net profit last quarter. The company is positioned in the mid-range of the industry, with relatively low attention from investors, making it a generally acceptable investment option.

Bond Features

Bond Scale: RMB 12.00 billion

Credit Rating: AA-

Conversion Value: RMB 97.43

Expected First-Day Premium Rate: Around 29%

Analysis: The bond scale is still acceptable, with a slightly lower credit rating and average conversion value. Considering the current premium rate is relatively low, it's expected that Garden Bonds will be listed at around RMB 126.

This article was first published on WeChat Public Number: Chicken Finance. The content represents the author's personal opinion and does not represent the position of Huxiu.com. Investors should operate based on this analysis, and please be aware of the risks.